{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:40:46Z","timestamp":1775025646285,"version":"3.50.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Spondyloenchondrodysplasia with immune dysregulation (SPENCD) is a rare autosomal recessive disorder caused by biallelic\n                      <jats:italic>ACP5<\/jats:italic>\n                      mutations and is characterized by skeletal dysplasia, neurological involvement, and immune dysregulation. According to the latest International Union of Immunological Societies (IUIS) classification, SPENCD is categorized as an inborn error of immunity within the autoinflammatory disorders spectrum; however, targeted therapeutic strategies for immune manifestations remain limited.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a multicenter study including five patients from India and from Chongqing and Tianjin, China. Whole-exome sequencing identified six\n                      <jats:italic>ACP5<\/jats:italic>\n                      variants across the five patients, including four novel variants. The diagnosis of SPENCD was established based on the genetic findings in combination with characteristic clinical features and radiological manifestations. Three patients received treatment with Janus kinase (JAK) inhibitors. In one representative treated patient (Patient 1), immunological parameters before and after treatment were evaluated using flow cytometry and quantitative PCR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Four novel\n                      <jats:italic>ACP5<\/jats:italic>\n                      variants were identified in this cohort. All three patients treated with tofacitinib (a JAK inhibitor) showed variable but overall clinical improvement. In one representative patient, immunological changes were observed after treatment, including a reduction in CD21\n                      <jats:sup>low<\/jats:sup>\n                      B cells and changes in T helper cell subsets.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study expands the spectrum of\n                      <jats:italic>ACP5<\/jats:italic>\n                      mutations and provides clinical and immunological observations suggesting JAK inhibitor therapy may be considered for immune dysregulation in patients with SPENCD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1788476","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:44:04Z","timestamp":1775018644000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Janus kinase inhibitor therapy for the treatment of spondyloenchondrodysplasia with immune dysregulation due to novel ACP5 variants: a multicenter study"],"prefix":"10.3389","volume":"17","author":[{"given":"Huilin","family":"Mu","sequence":"first","affiliation":[{"name":"National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, China International Science and Technology Cooperation base of Child development and Critical Disorders, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[{"name":"Tianjin Children\u2019s Hospital (Tianjin University Children\u2019s Hospital)","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongwen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Chongqing University Three Gorges Hospital","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Chen","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, China International Science and Technology Cooperation base of Child development and Critical Disorders, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[{"name":"Tianjin Children\u2019s Hospital (Tianjin University Children\u2019s Hospital)","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfeng","family":"Wu","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, China International Science and Technology Cooperation base of Child development and Critical Disorders, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"Department of Rheumatology and Immunology, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, China International Science and Technology Cooperation base of Child development and Critical Disorders, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"Department of Rheumatology and Immunology, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Tang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, China International Science and Technology Cooperation base of Child development and Critical Disorders, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"Department of Rheumatology and Immunology, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Zhou","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, China International Science and Technology Cooperation base of Child development and Critical Disorders, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"Department of Rheumatology and Immunology, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjun","family":"Jia","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, China International Science and Technology Cooperation base of Child development and Critical Disorders, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"Department of Rheumatology and Immunology, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratap Kumar","family":"Patra","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, All India Institute of Medical Sciences","place":["Patna, Bihar, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisar Ahmad","family":"Wani","sequence":"additional","affiliation":[{"name":"Department of Pediatric Radiology, Government Medical College","place":["Srinagar, Kashmir, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saniya","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Edison Hospital","place":["Mohali, Punjab, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zhao","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, China International Science and Technology Cooperation base of Child development and Critical Disorders, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"Department of Rheumatology and Immunology, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaqib Zaffar","family":"Banday","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Government Medical College","place":["Srinagar, Kashmir, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfei","family":"An","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, China International Science and Technology Cooperation base of Child development and Critical Disorders, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"Department of Rheumatology and Immunology, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1148\/118.1.133","article-title":"Spondyloenchondrodysplasia: enchondromatosis with severe platyspondyly in two brothers","volume":"118","author":"Schorr","year":"1976","journal-title":"Radiology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.749","article-title":"Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity","volume":"43","author":"Lausch","year":"2011","journal-title":"Nat Genet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/ng.748","article-title":"Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature","volume":"43","author":"Briggs","year":"2011","journal-title":"Nat Genet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.31081","article-title":"Spondyloenchondrodysplasia with spasticity, cerebral calcifications, and immune dysregulation: clinical and radiographic delineation of a pleiotropic disorder","volume":"140","author":"Renella","year":"2006","journal-title":"Am J Med Genet A"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-016-0252-y","article-title":"Spondyloenchondrodysplasia due to mutations in ACP5: a comprehensive survey","volume":"36","author":"Briggs","year":"2016","journal-title":"J Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.32518","article-title":"Two further cases of spondyloenchondrodysplasia (SPENCD) with immune dysregulation","author":"Navarro","year":"2008","journal-title":"Am J Med Genet A"},{"key":"B7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12969-015-0035-7","article-title":"Severe immune dysregulation with neurological impairment and minor bone changes in a child with spondyloenchondrodysplasia due to two novel mutations in the ACP5 gene","volume":"13","author":"Girschick","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2001.01145.x","article-title":"Mice lacking tartrate-resistant acid phosphatase (Acp5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen Staphylococcus aureus","volume":"102","author":"Bune","year":"2001","journal-title":"Immunology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/ni1327","article-title":"Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells","volume":"7","author":"Shinohara","year":"2006","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh558","article-title":"Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus","volume":"44","author":"Wong","year":"2005","journal-title":"Rheumatol (Oxford)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00633-9","article-title":"The type I interferonopathies: 10 years on","volume":"22","author":"Crow","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.825367","article-title":"Janus kinase inhibitors in the treatment of type I interferonopathies: a case series from a single center in China","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-016-0359-1","article-title":"Assessment of type I interferon signaling in pediatric inflammatory disease","volume":"37","author":"Rice","year":"2017","journal-title":"J Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-020-03636-x","article-title":"Monogenic lupus with IgA nephropathy caused by spondyloenchondrodysplasia with immune dysregulation","volume":"88","author":"Sait","year":"2021","journal-title":"Indian J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102891","article-title":"Regulatory B cells in patients suffering from inborn errors of immunity with severe immune dysregulation","volume":"132","author":"Bakhtiar","year":"2022","journal-title":"J Autoimmun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"eabh0891","DOI":"10.1126\/sciimmunol.abh0891","article-title":"The expansion of human T-bethighCD21low B cells is T cell dependent","volume":"6","author":"Keller","year":"2021","journal-title":"Sci Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.12.005","article-title":"The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells","volume":"41","author":"Sage","year":"2014","journal-title":"Immunity"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1126\/science.1062960","article-title":"The influence of the proinflammatory cytokine osteopontin on autoimmune demyelinating disease","volume":"294","author":"Chabas","year":"2001","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nri2460","article-title":"Regulation of T-helper-cell lineage development by osteopontin: the inside story","volume":"9","author":"Cantor","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26195","article-title":"Childhood-onset autoimmune cytopenia as the presenting feature of biallelic ACP5 mutations","volume":"64","author":"Sacri","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-016-0430-0","article-title":"Benefit and risk of tofacitinib in the treatment of rheumatoid arthritis: a focus on herpes zoster","volume":"39","author":"Yamaoka","year":"2016","journal-title":"Drug Saf"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00438-023-02009-1","article-title":"Spondyloenchondrodysplasia in five new patients: identification of three novel ACP5 variants with variable neurological presentations","volume":"298","author":"Elhossini","year":"2023","journal-title":"Mol Genet Genomics"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1788476\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:44:19Z","timestamp":1775018659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1788476\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":24,"alternative-id":["10.3389\/fimmu.2026.1788476"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1788476","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"1788476"}}